Dickinson, Harriet; Teltsch, Dana Y; Feifel, Jan; Hunt, Philip; Vallejo-Yagüe, Enriqueta; Virkud, Arti V; Muylle, Katoo M; Ochi, Taichi; Donneyong, Macarius; Zabinski, Joseph; Strauss, Victoria Y; Hincapie-Castillo, Juan M (2024). The Unseen Hand: AI-Based Prescribing Decision Support Tools and the Evaluation of Drug Safety and Effectiveness [opinion]. Drug safety, 47(2), pp. 117-123. Springer 10.1007/s40264-023-01376-3
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
Dickinson_DrugSaf_2024.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Authors hold Copyright Download (624kB) |
The use of artificial intelligence (AI)-based tools to guide prescribing decisions is full of promise and may enhance patient outcomes. These tools can perform actions such as choosing the 'safest' medication, choosing between competing medications, promoting de-prescribing or even predicting non-adherence. These tools can exist in a variety of formats; for example, they may be directly integrated into electronic medical records or they may exist in a stand-alone website accessible by a web browser. One potential impact of these tools is that they could manipulate our understanding of the benefit-risk of medicines in the real world. Currently, the benefit risk of approved medications is assessed according to carefully planned agreements covering spontaneous reporting systems and planned surveillance studies. But AI-based tools may limit or even block prescription to high-risk patients or prevent off-label use. The uptake and temporal availability of these tools may be uneven across healthcare systems and geographies, creating artefacts in data that are difficult to account for. It is also hard to estimate the 'true impact' that a tool had on a prescribing decision. International borders may also be highly porous to these tools, especially in cases where tools are available over the web. These tools already exist, and their use is likely to increase in the coming years. How they can be accounted for in benefit-risk decisions is yet to be seen.
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Medical Education > Institute of General Practice and Primary Care (BIHAM) |
UniBE Contributor: |
Vallejo Yagüe, Enriqueta |
Subjects: |
600 Technology > 610 Medicine & health 300 Social sciences, sociology & anthropology > 360 Social problems & social services |
ISSN: |
1179-1942 |
Publisher: |
Springer |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
30 Nov 2023 12:40 |
Last Modified: |
01 Feb 2024 15:52 |
Publisher DOI: |
10.1007/s40264-023-01376-3 |
PubMed ID: |
38019365 |
BORIS DOI: |
10.48350/189640 |
URI: |
https://boris.unibe.ch/id/eprint/189640 |
Actions (login required)
 |
Edit item |